TLR2 and neoplasm: A novel inhibitor of TLR-2, ortho vanillin, inhibited MMP-9, MMP-14, IL-6, and iNOS expression and decreased TLR-2-mediated pro-tumor M2 phenotype of brain resident macrophages [252].